Logo 1 Logo 2

Clinical Trial Details

Trial ID: L1935
Source ID: NCT00044694
Associated Drug: Placebo 0.01 Ml
Title: Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes Mellitus, Non-Insulin-Dependent
Interventions: DRUG: Placebo 0.01 mL|DRUG: Placebo 0.02 mL|DRUG: Placebo 0.03 mL|DRUG: Placebo 0.04 mL|DRUG: AC2993 2.5 mcg|DRUG: AC2993 5.0 mcg|DRUG: AC2993 7.5 mcg|DRUG: AC2993 10.0 mcg
Outcome Measures: Primary: Change in HbA1c (glycosylated hemoglobin) from Baseline to Day 28, Change in HbA1c from Baseline (Day 1) to study termination (Day 28), Baseline (Day 1) to Day 28 | Secondary: Change in HbA1c from Baseline to Day 14, Change in HbA1c from Baseline (Day 1) to Day 14, Baseline, Day 14|Change in fasting plasma glucose from Baseline to Day 14 and to Day 28, Change in fasting plasma glucose from Baseline (Day 1) to Day 14 and to study termination (Day 28), Baseline, Day 14, Day28|Change in serum fructosamine from Baseline (Day 1) to Day 14 and to Day 28, Change in serum fructosamine from baseline (Day 1) to Visit 4 (Day 14) and to study termination (Day 28), Baseline, Day 14, Day 28
Sponsor/Collaborators: Sponsor: AstraZeneca
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 156
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Start Date: 2002-08
Completion Date: 2003-05
Results First Posted:
Last Update Posted: 2015-02-20
Locations: Innovative Clinical Trials, Birmingham, Alabama, 35209, United States|Healthsouth Clinical Research, Birmingham, Alabama, 35243, United States|Endocrinology Clinic of O.C., Anaheim, California, 92801, United States|Pioneer Medical Group, Bellflower, California, 90706, United States|International Clinical Research Network, Chula Vista, California, 91910, United States|Bautista Research and Medical Clinic, Fresno, California, 93721, United States|Whittier Institute for Diabetes, La Jolla, California, 92037, United States|Richard Cherlin, M.D., Los Gatos, California, 95032, United States|Dr. Martinez Medical Clinic, Moreno Valley, California, 92553, United States|Anshutz Outpatient Pavilion, Aurora, Colorado, 80010, United States|Diagnostic Clinic, Clearwater, Florida, 33760, United States|Radiant Research-Gainsville, Gainsville, Florida, 32605, United States|Jacksonville Center for Clinical Research, Jacksonville, Florida, 32216, United States|Radiant Research-Pinellas Park, Pinellas Park, Florida, 33781, United States|Clinical Research Group of North Georgia, Blairsville, Georgia, 30512, United States|East-West Medical Research Institute, Honolulu, Hawaii, 96813, United States|Radiant Research-Honolulu, Honolulu, Hawaii, 96814, United States|Radiant Research-Boise, Boise, Idaho, 83704, United States|Cedar-Crosse Research Center, Chicago, Illinois, 60607, United States|Northshore Medical Research, LLC, Covington, Louisiana, 70433, United States|Medical Research Institute, Slidell, Louisiana, 70458, United States|Melvin Kramer, MD, Concord, Massachusetts, 01742, United States|Radiant Research-Edina, Edina, Minnesota, 55435, United States|Mississippi Medical Research, LLC, Gulfport, Mississippi, 39501, United States|The Center for Pharmaceutical Research, Kansas City, Missouri, 64114, United States|Innovative Health Research, Las Vegas, Nevada, 89119, United States|Carolina Advanced Research, Cary, North Carolina, 27511, United States|Fallen Timbers Internal Medicine, LLC, Maumee, Ohio, 43537, United States|Millenium Research, Benbrook, Texas, 76126, United States|Healthsouth Clinical Research, Desoto, Texas, 75115, United States|Baylor College of Medicine/Clinical Studies Unit, Houston, Texas, 77030, United States|Diabetes Center of the Southwest, Midland, Texas, 79705, United States|Utah Diabetes Center at the University of Utah, Salt Lake City, Utah, 84108, United States
URL: https://clinicaltrials.gov/show/NCT00044694

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress